Emergent BioSolutions
EBS
#8180
Rank
NZ$0.61 B
Marketcap
NZ$12.09
Share price
-5.68%
Change (1 day)
-25.88%
Change (1 year)

Emergent BioSolutions (EBS) - P/B ratio

P/B ratio as of October 2026 : 1.02

According to Emergent BioSolutions 's latest financial reports the company has a price-to-book ratio of 0.469701.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Emergent BioSolutions - P/B ratio (from 2006 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-311.2837.6%
2024-12-310.9281383.96%
2023-12-310.1918-54.83%
2022-12-310.4246-70.74%
2021-12-311.45-55.78%
2020-12-313.2828.07%
2019-12-312.56-14.65%
2018-12-313.0018.13%
2017-12-312.5413.93%
2016-12-312.23-6.62%
2015-12-312.3928.7%
2014-12-311.867.84%
2013-12-311.7232.27%
2012-12-311.30-10.43%
2011-12-311.45-33.92%
2010-12-312.2027.95%
2009-12-311.72-56.15%
2008-12-313.92345.58%
2007-12-310.8795-60.46%
2006-12-312.22
2005-12-31N/A
2004-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
2.03 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
8.81 762.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
4.36 327.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
2.52 146.31%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
1.33 30.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
3.23 216.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
6.24 510.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel